| Total (n = 155) | Survivors (n = 103) | Non-survivors (n = 52) | p value |
---|---|---|---|---|
Age | 63.4 ± 18.4 | 63.96 ± 19.04 | 62.2 ± 17.1 | 0.577 |
Gender (male) | 115(74.2%) | 78 (75.7%) | 37 (71.2%) | 0.539 |
Basic Scr(μmol/L) | 79.5 (61.0-100.0) | 78.5 (61.3-98.5) | 80.5 (58.8-102.0) | 0.501 |
Scr when AKI diagnosed (μmol/L) | 165 (132-237) | 158 (126-216) | 190.5 (142.5-241.5) | 0.030 |
RIFLE criteria (%) | Â | Â | Â | 0.235 |
   Risk | 71 (45.8%) | 50 (48.5%) | 21 (40.4%) |  |
   Injury | 38 (24.5%) | 27 (26.2%) | 11 (21.2%) |  |
   Failure | 46 (29.7%) | 26 (25.2%) | 20 (38.5%) |  |
Etiology of AKI | Â | Â | Â | 0.513 |
   Ischemic | 66 (42.6%) | 44 (42.7%) | 22 (42.3%) |  |
   Multifaceted | 58 (37.4%) | 36 (35.0%) | 22 (42.3%) |  |
   Nephrotoxic | 31 (20.0%) | 23 (22.3%) | 8 (15.4%) |  |
Comorbidity | Â | Â | Â | Â |
   Hypertension | 66 (44.6%) | 40 (40.8%) | 26 (52.0%) | 0.195 |
   Diabetes | 25 (16.9%) | 19 (19.4%) | 6 (12.0%) | 0.257 |
   CKD | 10 (6.8%) | 10 (10.2%) | 0 (0%) | 0.017 |
   Sepsis | 67 (43.8%) | 41 (40.2%) | 26 (51.0%) | 0.205 |
Ventilation | 31 (20.0%) | 12 (11.7%) | 19 (36.5%) | <0.001 |
Dialysis | 30 (19.4%) | 18 (17.5%) | 12 (23.1%) | 0.405 |
Hemoglobin (g/dL) | 11.2 (9.6-12.6) | 11.2 ± 2.0 | 10.7 ± 3.1 | 0.265 |
WBC (103/mm3) | 11.2 (7.7-16.5) | 10.8 (7.1-16.9) | 12.1 (9.2-16.4) | 0.222 |
TB (mmol/L) | 12.0 (8.2-21.2) | 12.0 (8.0-18.5) | 13.0 (8.5-28.4) | 0.112 |
SOFA | 7 (4-11) | 4 (3-7) | 12.5 (9.3-15.0) | <0.001 |